v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
October 2025 Share Repurchase Program
October 2025 Share Repurchase Program - Put Option
Common stock
Common stock
October 2025 Share Repurchase Program
Common stock
October 2025 Share Repurchase Program - Put Option
Additional paid-in capital
Additional paid-in capital
October 2025 Share Repurchase Program
Additional paid-in capital
October 2025 Share Repurchase Program - Put Option
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024       112,550,156              
Beginning balance at Dec. 31, 2024 $ 455,656     $ 113     $ 1,193,022     $ 2,676 $ (740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation expense 32,255           32,255        
Common stock issued under employee stock plans (in shares)       1,808,876              
Common stock issued under employee stock plans 7,163     $ 2     7,161        
Taxes related to net share settlement of equity awards (26,447)           (26,447)        
Repurchase of common stock (in shares)       (1,476,456)              
Repurchase of common stock (61,264)     $ (2)     (61,262)        
Unrealized (loss) income on derivative instruments, net of tax (6,231)                 (6,231)  
Unrealized income (loss) on available for sale securities, net of tax 2,393                 2,393  
Common stock issued for debt conversion (in shares)       32              
Common stock issued for debt conversion 1           1        
Net loss (35,783)                   (35,783)
Ending balance (in shares) at Mar. 31, 2025       112,882,608              
Ending balance at Mar. 31, 2025 367,743     $ 113     1,144,730     (1,162) (775,938)
Beginning balance (in shares) at Dec. 31, 2024       112,550,156              
Beginning balance at Dec. 31, 2024 455,656     $ 113     1,193,022     2,676 (740,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Unrealized (loss) income on derivative instruments, net of tax 9,505                    
Unrealized income (loss) on available for sale securities, net of tax 2,316                    
Net loss (71,607)                    
Ending balance (in shares) at Jun. 30, 2025       112,047,109              
Ending balance at Jun. 30, 2025 341,499     $ 112     1,138,652     14,497 (811,762)
Beginning balance (in shares) at Mar. 31, 2025       112,882,608              
Beginning balance at Mar. 31, 2025 367,743     $ 113     1,144,730     (1,162) (775,938)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation expense 33,859           33,859        
Common stock issued under employee stock plans (in shares)       163,501              
Taxes related to net share settlement of equity awards (1,352)           (1,352)        
Repurchase of common stock (in shares)       (1,003,885)              
Repurchase of common stock (38,736)     $ (1)     (38,735)        
Unrealized (loss) income on derivative instruments, net of tax 15,736                 15,736  
Unrealized income (loss) on available for sale securities, net of tax (77)                 (77)  
Common stock issued for debt conversion (in shares)       4,885              
Common stock issued for debt conversion 150           150        
Net loss (35,824)                   (35,824)
Ending balance (in shares) at Jun. 30, 2025       112,047,109              
Ending balance at Jun. 30, 2025 341,499     $ 112     1,138,652     14,497 (811,762)
Beginning balance (in shares) at Dec. 31, 2025       117,546,852              
Beginning balance at Dec. 31, 2025 598,656     $ 118     1,444,885     23,132 (869,479)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation expense 33,739           33,739        
Common stock issued under employee stock plans (in shares)       2,622,743              
Common stock issued under employee stock plans 7,970     $ 2     7,968        
Taxes related to net share settlement of equity awards (17,386)           (17,386)        
Repurchase of common stock (in shares)         (4,429,520) (925,925)          
Repurchase of common stock   $ (110,000) $ (20,009)   $ (4) $ (1)   $ (109,996) $ (20,008)    
Unrealized (loss) income on derivative instruments, net of tax (952)                 (952)  
Unrealized income (loss) on available for sale securities, net of tax (1,651)                 (1,651)  
Net loss (36,854)                   (36,854)
Ending balance (in shares) at Mar. 31, 2026       114,814,150              
Ending balance at Mar. 31, 2026 453,513     $ 115     1,339,202     20,529 (906,333)
Beginning balance (in shares) at Dec. 31, 2025       117,546,852              
Beginning balance at Dec. 31, 2025 598,656     $ 118     1,444,885     23,132 (869,479)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Unrealized (loss) income on derivative instruments, net of tax 6,584                    
Unrealized income (loss) on available for sale securities, net of tax (2,557)                    
Net loss (83,663)                    
Ending balance (in shares) at Jun. 30, 2026       114,853,875              
Ending balance at Jun. 30, 2026 444,493     $ 115     1,370,361     27,159 (953,142)
Beginning balance (in shares) at Mar. 31, 2026       114,814,150              
Beginning balance at Mar. 31, 2026 453,513     $ 115     1,339,202     20,529 (906,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation expense 34,619           34,619        
Common stock issued under employee stock plans (in shares)       39,725              
Taxes related to net share settlement of equity awards (3,460)           (3,460)        
Unrealized (loss) income on derivative instruments, net of tax 7,536                 7,536  
Unrealized income (loss) on available for sale securities, net of tax (906)                 (906)  
Net loss (46,809)                   (46,809)
Ending balance (in shares) at Jun. 30, 2026       114,853,875              
Ending balance at Jun. 30, 2026 $ 444,493     $ 115     $ 1,370,361     $ 27,159 $ (953,142)